MedTrace Logo

Biomarker Analysis of Central Nervous System Tumors

NCT02692898 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2019-11-19

No results posted yet for this study

Summary

Background:

The number of people who get tumors of the brain or central nervous system (CNS) is lower than other cancers. But these tumors cause a higher rate of serious effects and even death. Researchers want to test existing samples of tissue from these tumors to learn more about them. This may lead to better treatment.

Objective:

To study stored samples of CNS tumors to learn more about the tumors and explore new ways to diagnose them.

Eligibility:

The study will use tissue samples already collected at NIH from people with brain or CNS tumors.

Design:

The participants will have given their consent in a previous study.

Researchers will review the tissue samples and any data collected about them.

Researchers will do lab tests and scans on the samples.

All data will be kept secure.

Conditions

  • Central Nervous System Neoplasms
  • Primary Brain Neoplasms
  • Neoplasms, Brain
  • Cancer of the Brain
  • Brain Cancer

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Terri S Armstrong, C.R.N.P. · National Cancer Institute (NCI)

Eligibility

Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-25
Primary Completion
2019-11-15
Completion
2019-11-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02692898 on ClinicalTrials.gov